A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders
Conditions: Sleep Disorder Sponsors: Itamar-Medical, Israel Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
A Multicenter Randomized Clinical Trial (RCT) of Ventilation for Acute Respiratory Distress Syndrome (ARDS)
Conditions: Acute Respiratory Distress Syndrome; Respiratory Failure Interventions: Other: Precision ventilation; Other: Guided usual care ventilation Sponsors: Beth Israel Deaconess Medical Center; Columbia University; Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
RedHill and U.S. Army Announce Opaganib's Ebola Virus Disease Survival Benefit in U.S. Army-Funded In-Vivo Study
TEL AVIV, Israel and RALEIGH, NC, Oct. 3, 2023. RedHill Biopharma Ltd. ( " RedHill " or the " Company " ), a specialty biopharmaceutical company, today announced that novel, twice daily, oral opaganib[1], delivered a statistically significant increase in... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 3, 2023 Category: Pharmaceuticals Source Type: clinical trials
PEA vs. Placebo for Major Depression
Conditions: Bipolar Depression; Major Depressive Disorder Interventions: Drug: Palmitoylethanolamide Sponsors: The Israeli Medical Center for Alzheimer ' s Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials
SciSparc Initiated Its Clinical Trial with SCI-210 in Pediatrics with Autism Spectrum Disorder
TEL AVIV, Israel, Sept. 29, 2023. SciSparc Ltd. ( " Company " or " SciSparc " ), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare disease of the central nervous system, today announced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 29, 2023 Category: Pharmaceuticals Source Type: clinical trials
T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer
Condition: Non-small Cell Lung Cancer Metastatic Intervention: Sponsors: Ari Raphael; Bar-Ilan University, Israel; Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer
Conditions: Non-small Cell Lung Cancer Metastatic Sponsors: Ari Raphael; Bar-Ilan University, Israel; Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Mind Body Intervention for Long COVID
Conditions: Long COVID; Post-Acute Sequelae of COVID-19; COVID Long-Haul Interventions: Behavioral: Mind Body Intervention #1 Sponsors: Beth Israel Deaconess Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
